baber/WOPTO huggingface dataset:
Patent AU-2020375429-A1 (AU)
Title: Battery module, and battery rack and power storage device comprising battery module
Inventor: YOO JAE-MIN
IPC: H01M50/20
Filed: 2020-10-19
Abstract: A battery module according to an embodiment of the present invention comprises: battery cells; a module case for accommodating the battery cells and having an inner cooling flow path on both sides of the battery cells; venting openings provided on both lateral surfaces of the module case; sheet members which are mounted on both lateral surfaces of the module case, so as to cover the venting openings, and melt at a predetermined temperature or higher to open the venting openings; and barrier brackets positioned a predetermined distance away from the sheet members and mounted on the inner walls of both lateral surfaces of the module case.
Patent AU-2020395451-A1 (AU)
Title: Method for processing plastic pyrolysis oils with a view to their use in a steam-cracking unit
Inventor: WEISS WILFRIED
IPC: C10G69/06
Filed: 2020-11-16
Abstract: The present invention concerns a method for processing a plastic pyrolysis oil, comprising: a) a step of selective hydrogenation of the feedstock in the presence of hydrogen and at least one selective hydrogenation catalyst, at a temperature between 100 and 150°C, a partial pressure of hydrogen between 1.0 and 10.0 MPa absolute and an hourly space velocity between 1.0 and 10.0 h-1, in order to obtain a hydrogen effluent; b) a step of hydroprocessing said hydrogen effluent in the presence of hydrogen and at least one hydroprocessing catalyst, at a temperature between 250 and 370°C, a partial pressure of hydrogen between 1.0 and 10.0 MPa absolute and an hourly space velocity between 0.1 and 10.0 h-1, in order to obtain a hydroprocessing effluent; c) a step of separating the hydroprocessing effluent originating from step b) in the presence of an aqueous flow, said step being performed at a temperature between 50 and 370°C, in order to obtain at least one gaseous effluent, one aqueous liquid effluent and one hydrocarbon liquid effluent.
Patent AU-2020403127-A1 (AU)
Title: Cutting machine having a reduced form factor
Inventor: CRYSTAL JEREMY BURTON
IPC: B26D5/06
Filed: 2020-12-11
Abstract: A cutting machine includes a working surface, a carriage, a tool, and a drive mechanism. The carriage is disposed above the working surface. The tool is removably secured to the carriage and configured to move (i) toward the working surface along a first axis, (ii) relative to the working surface along a second axis transverse to the first axis, and (iii) relative to the working surface along a third axis transverse to the first axis and the second axis. The drive mechanism is offset from the first axis and configured to move the tool along the first axis.
Patent AU-2020405221-A1 (AU)
Title: Personal care compositions and methods for the same
Inventor: WU QIANG
IPC: A61K8/92
Filed: 2020-12-02
Abstract: Personal care compositions and methods for treating one or more dry skin conditions are disclosed. The composition may include a carrier, one or more plant oils, and a source of Aloe vera. The one or more plant oils and the source of Aloe vera may each be present in an effective amount to increase natural moisturizing factors in skin when applied thereto. The method for treating the one or more dry skin conditions may include contacting the personal care composition with skin. Contacting the personal care composition with the skin may increase an amount of natural moisturizing factors in the skin and/or increase an amount of Caspase-14 in the skin.
Patent AU-2020416052-A1 (AU)
Title: Oral solutions comprising lisdexamfetamine salts
Inventor: LIOLIOS GEORGIOS
IPC: A61K9/08
Filed: 2020-04-16
Abstract: Oral pharmaceutical solution comprising a pharmaceutically acceptable salt of lisdexamfetamine, and a pharmaceutically acceptable aqueous carrier comprising a buffer and a cosolvent selected from the group consisting of a glycol, a polyol, and a mixture thereof, wherein the pH of the solution is from 5.5 to 9.0. The oral pharmaceutical solution presents excellent physicochemical stability, even under alkaline conditions.
Patent AU-2021200127-A1 (AU)
Title: Delivery of negatively charged proteins using cationic lipids
Inventor: LIU DAVID R
IPC: C07K14/435
Filed: 2021-01-11
Abstract: Compositions, methods, strategies, kits, and systems for the delivery of negatively charged 
proteins, protein complexes, and fusion proteins, using cationic polymers or lipids are provided.  
Delivery of proteins into cells can be effected in vivo, ex vivo, or in vitro. Proteins that can be 
delivered using the compositions, methods, strategies, kits, and systems provided herein 
include, without limitation, enzymes, transcription factors, genome editing proteins, Cas9 
proteins, TALEs, TALENs, nucleases, binding proteins (e.g., ligands, receptors, antibodies, 
antibody fragments; nucleic acid binding proteins, etc.), structural proteins, and therapeutic 
proteins (e.g., tumor suppressor proteins, therapeutic enzymes, growth factors, growth factor 
receptors, transcription factors, proteases, etc.), as well as variants and fusions of such proteins.  
See Fig. 27B.
WO 2016/070129 PCT/US2015/058479 
18/63 
.. Net negatively 
Cationic lipids .  charged protein 
Treatment of 
mammalian cells with 
cationic lipid:anionic 
protein complexes 
Extracellular space 
Cytoplasm ¼Liposome 
4yendocytosis 
Endosomal 
escape 
Endosome 
FIG. 27BL2 
SUBSTITUTE SHEET (RULE 26)
Patent AU-2021201237-A1 (AU)
Title: Bone plating system and method
Inventor: DAYTON PAUL
IPC: A61B17/80
Filed: 2021-02-25
Abstract: A bone plate can be used to fixate one or more bones. In some examples, the bone plate 
defines an elongated body having a plurality of fixation holes arrayed at different points along 
the length of the body. For example, the bone plate may have opposed fixation holes separated 
by a bridge. The bone plate may be bent or shaped along a central longitudinal axis extending 
through the elongated body and also twisted around the central longitudinal axis. The bending 
and twisting can position each fixation hole of the elongated body in a different plane in three
dimensional space.
WO 2016/112178 PCT/US2016/O12462 
5/15 
C)) 
100 
T/ 
00 
/0) 
mCC) 
0)0
Patent AU-2021209274-A1 (AU)
Title: Retail merchandise tray with improved mounting, spacing, and locating
Inventor: NAGEL THOMAS O
IPC: A47F3/14
Filed: 2021-07-29
Abstract: RETAIL MERCHANDISE TRAY WITH IMPROVED MOUNTING, SPACING, 
AND LOCATING 
ABSTRACT 
A retail merchandise tray is provided. The retail merchandise tray may have a load 
bearing member formed from a rail attached to a mounting plate. The mounting plate and rail 
forming a downward opening notch for mounting to a tray support structure. The tray may 
have a locating flange that carries a locating pin that engages a tray support structure. The 
locating pin locating the tray along the tray support structure. The tray may have at least one 
divider assembly. The divider assembly includes outward extending offset projections that 
can prevent an adjacent tray from contacting the divider wall.
Patent AU-2021209845-A1 (AU)
Title: Vial adapter device
Inventor: YAN BO
IPC: A61J1/20
Filed: 2021-01-18
Abstract: A vial adapter configured to allow direct fluid withdrawal with a syringe from a fluid container having a self-healing sealing member is described. The syringe is connected to the vial adapter by a vial adapter connecting member and a corresponding syringe connecting member. In use, the fluid container is pressed against the vial adapter, and the vial adapter removably locks the fluid container to the vial adapter. When removably locked, a stake of the vial adapter pierces the sealing member.
Patent AU-2021215260-A1 (AU)
Title: SSTR-targeted conjugates and particles and formulations thereof
Inventor: WOOSTER RICHARD
IPC: A61P35/00
Filed: 2021-08-13
Abstract: [0001] Conjugates of an active agent such as DM1 attached to a targeting moiety, 
such as a somatostatin receptor binding moiety, via a linker, and particles comprising 
such conjugates have been designed. Such conjugates and particles can provide 
improved temporospatial delivery of the active agent, improved biodistribution and 
penetration in tumor, and/or decreased toxicity. Methods of making the conjugates, 
the particles, and the formulations thereof are provided. Methods of administering the 
formulations to a subject in need thereof are provided, for example, to treat or prevent 
cancer.  
1
Patent AU-2021217241-A1 (AU)
Title: Machine learning prediction of therapy response
Inventor: ISSLER ERAN
IPC: G16B40/00
Filed: 2021-02-07
Abstract: A method comprising receiving, for each of a plurality of subjects having a specified type of disease and receiving a specified therapy for treating the disease, a first biological signature obtained pre-treatment and a second biological signature obtained on-treatment; calculating, for each of the plurality of subjects, a set of values representing a ratio between the first and second biological signatures associated with the respective subject; at a training stage, training a machine learning model on a training set comprising: (i) the calculated sets of values, and (ii) labels associated with an outcome of the specified therapy in each of the subjects; to generate a classifier suitable for predicting a response in a target patient to said specified therapy.
Patent AU-2021224002-A1 (AU)
Title: Mineral-containing composition for producing ice for improving flavor of water or beverage
Inventor: Teramoto yuki
IPC: A23L2/00
Filed: 2021-02-18
Abstract: In the present invention, ice that is capable of improving flavor when added to water or a beverage is produced.　Provided is a mineral-containing composition which is characterized in that, among metal ions present in the mineral-containing composition, calcium ions are contained at the highest concentration .
Patent AU-2021235832-A1 (AU)
Title: Pharmaceutical composition for prevention or treatment of nonalcoholic steatohepatitis
Inventor: KIM MI-KYUNG
IPC: A61K31/506
Filed: 2021-03-10
Abstract: The present invention relates to a pharmaceutical composition for preventing or treating nonalcoholic fatty liver disease. The pharmaceutical composition according to the present invention exhibits excellent effects of improving lipid metabolism, reducing fat accumulation in liver tissues and inhibiting histological damage caused by inflammation and fibrosis of liver tissues, and thus can be effectively used as a use of preventing or treating nonalcoholic fatty liver disease.
Patent AU-2021238846-A1 (AU)
Title: Wave energy conversion system
Inventor: VIGARS PAUL
IPC: F03B13/18
Filed: 2021-03-19
Abstract: Disclosed is a WEC module for connection to a WEC system having a power take-off (PTO) configured to generate electricity in response to fluid flow in a fluid flow path of the system. The module comprises a mounting portion for releasably mounting the module to the system, a deformable sealing member configured to provide a sealed fluid connection between the module and the fluid flow path, and a working surface configured to exchange, in response to wave motion, a working fluid with the fluid flow path via the sealed fluid connection. Also disclosed is a WEC system and a method of deploying the WEC module. Also disclosed is an installation device for a working surface and a method of installing a working surface.
Patent AU-2021250033-A1 (AU)
Title: Medical syringe plunger and medical finger grip
Inventor: YOSHIDA TAKAYUKI
IPC: A61M5/50
Filed: 2021-03-31
Abstract: Provided are a plunger and a finger grip which can be used in a medical disposable syringe and have both of a dose accuracy function and a pull out prevention function.　A plunger rod comprises: a first guide groove which can guide the axis-direction movement of a projection that is arranged toward the center of a hole in a finger grip upon the entering of the projection into the first guide groove; a second guide groove which is arranged at a position which is rotated by a specific angle in the direction of the periphery of the plunger rod relative to the first guide groove and can guide the axis-direction movement; an axis-direction movement restriction unit which is arranged in the vicinity of an end of the first guide groove and can restrict the axis-direction movement; and a projection movement unit which enables the movement of the projection from the first guide groove to the second guide groove.
Patent AU-2021251690-A1 (AU)
Title: Arginine methyltransferase 5 (PRMT5) degraders and uses thereof
Inventor: QI JUN
IPC: A61K31/415
Filed: 2021-04-05
Abstract: Disclosed are to bifunctional compounds that target PRMT5 for degradation, compositions, and methods for treating diseases or conditions mediated by aberrant arginine methyltransferase 5 (PRMT5) activity.
Patent AU-2021258041-A1 (AU)
Title: A sliding and folding hard roofed tent, with integrated walls and floor, which mounts onto a vehicle and opens onto the ground.
Inventor: ROULAND MATTHEW
IPC: E04H15/06
Filed: 2021-10-28
Abstract: : 
The 'TorFlyTent' is a tent within a pod which can be mounted on the roof racks of a vehicle, trailer or 
other suitable structure. The pod is comprised of an upper and lower section which is hinged on one 
side. Each section is shaped like a box without its lid, howeverwhen the sections are joined, they 
forma closed box like shape. Slides are attached to the left and right side of the upper section which 
are in turn attached to an external frame. The external frame can be mounted to roof racks or some 
other suitable structure and it has the provision for roof racks or a platform to be attached to it.  
When the pod is suspended'within'the external frame it is in its stored or travel condition and 
cannot be used as a tent. To erect the tent, the pod is extended from the externalframe and the 
lowersection of the pod opens in a downward arc to reveal the tent which consists of integrated 
walls and floor. The lower section is moved to roughly the same plane as the upper section, where it 
is supported by the use of integrated telescopicpoles. Both the upper and lower sections now form 
the hard roof of the tent structure. The upper ends of the tent walls are attached to the inside of the 
upper and lowe rsections of the pod. No additional poles, pegs or ropes are required to maintain the 
shape of the tent. Roof racks or a platform can be mounted above the external frame and do not 
have any impact upon the operation of the tent.
FIGURE4: 
This image depicts the leadingedge (front) of the 'To rFlyTent' pod as it sits mounted on the roof 
racks of a vehicle. Visible at the leading edge is the hinge and the slide locking mechanism. The pod 
is suspended within the external frame by the two slides on the left and right sides of the upper 
section. Also visible are two mounting points for roof packs or a platform.  
FIGURE: 
This image depictsthe leftside of the 'TorFlyTent'pod as it sits mounted onthe roof racks of a 
vehicle.The pod isextended from the external skeletontothe side of the vehi cle andthe pod is in 
the closed position with the tent housed within.  
FIGURE: 
This image depicts the left side of the 'TorFlyTent'pod as it is extended from the external skeleton.  
The over centre fasteners on the back of the pod have been released and the ratchet strap is used to 
control the opening of the lowersection from the upper section. The tent can be seen within the 
pod.
Patent AU-2021269386-A1 (AU)
Title: Apparatus and methods for assisted breathing by transvascular nerve stimulation
Inventor: THAKKAR VIRAL
IPC: A61N1/36
Filed: 2021-11-18
Abstract: A catheter may include electrodes for transvascular nerve stimulation. The 
electrodes may be positioned within lumens of the catheter and aligned with apertures 
in the outer wall of the catheter. The electrodes may produce focused electrical fields 
for stimulation of one or more nerves. In one embodiment, the catheter may include a 
set of proximal electrodes and a set of distal electrodes, and the proximal electrodes 
may stimulate a patient's left phrenic nerve and the distal electrodes may stimulate a 
patient's right phrenic nerve.
Patent AU-2021273447-A1 (AU)
Title: Redirection of tropism of AAV capsids
Inventor: NONNENMACHER MATHIEU E
IPC: C07K14/005
Filed: 2021-03-31
Abstract: The disclosure relates to compositions, methods, and processes for the preparation, use, and/or formulation of adeno-associated virus capsid proteins, wherein the capsid proteins comprise targeting peptide inserts tor enhanced tropism to a target tissue.
Patent AU-2021287998-A1 (AU)
Title: Methods and compositions for preventing type 1 diabetes
Inventor: LEON FRANCISCO
IPC: C07K16/28
Filed: 2021-06-11
Abstract: Provided herein, in one aspect, is a method of preventing or delaying the onset of clinical type 1 diabetes (T1D), comprising: providing a non-diabetic subject who is at risk for T1D; administering a prophylactically effective amount of an anti-CD3 antibody to the non-diabetic subject; and determining, prior to or after the administering step, that the non-diabetic subject has more than about 5% to more than about 10% TIGIT+KLRG1+CD8+ T-cells in all CD3+ T cells, which is indicative of successful prevention or delay of the onset of clinical T1D.
Patent AU-2021289611-A1 (AU)
Title: Patient interface
Inventor: SCHEINER RUPERT CHRISTIAN
IPC: A61M16/06
Filed: 2021-06-09
Abstract: A patient interface is disclosed that includes: a plenum chamber pressurisable to a therapeutic pressure; a seal-forming structure joined to the plenum chamber and comprising a nasal portion, an oral portion, and at least one hole configured to deliver a flow of air at said therapeutic pressure to at least the patient's nares in use, the seal-forming structure constructed and arranged to maintain said therapeutic pressure in the plenum chamber throughout the patient's respiratory cycle in use; a vent comprising a plurality of holes configured to allow a continuous vent flow from an interior of the plenum chamber to ambient; a positioning and stabilising structure comprising at least one tie and being configured to hold the seal-forming structure in a therapeutically effective position on the patient's head in use; and a textile portion configured to contact the patient's face.
Patent AU-2021290204-A1 (AU)
Title: Predictive ammonia release control
Inventor: RAMIREZ JORGE RAFAEL LOZADA
IPC: B01D53/86
Filed: 2021-12-20
Abstract: OF THE DISCLOSURE 
Embodiments are directed towards controlling uncontrolled release of ammonia 
from an engine of a vehicle. An estimated status of the engine is determined prior to an event, 
such as an estimated load on the engine prior to the vehicle going up a hill. A predictive model 
of uncontrolled ammonia release is generated for the estimated status. At least one engine
related countermeasure is selected based on the predictive model. If the predictive model of 
uncontrolled ammonia release with the selected countermeasures satisfies a threshold condition, 
then the selected engine-related countermeasure is employed.
Q) 
Cv) 
7E~ CC) 
2:C) _ 'C) t 
C) E 
I H I 
-C) CU 
C> E 
00
- --r- E 
0 E.C)__ _ _ _
Patent AU-2021326319-A1 (AU)
Title: Stent
Inventor: SHOBAYASHI YASUHIRO
IPC: A61F2/90
Filed: 2021-08-11
Abstract: Provided is a stent that has increased patency against bends.　A stent 10 comprises a plurality of wavy-line pattern bodies 11 and a plurality of connection elements 12. The wavy-line pattern is formed of a plurality of waveform units 14 each having: a first leg portion 15; a second leg portion 16; a third leg portion 17; a first apex portion 18 coupling a first end 15a of the first leg portion 15 and a first end 16a of the second leg portion 16; and a second apex portion 19 coupling a second end 16b of the second leg portion 16 and a first end 17a of the third leg portion 17. A second end 17b of the third leg portion 17 is connected to a second end 15b of the first leg portion 15 of a waveform unit 14 circumferentially adjacent about an axis. A first end 12a of the connection element 12 is connected to the first apex portion 18 of one of waveform units 14 axially adjacent to each other, and a second end 12b of the connection element 12 is connected to the second end 15b of the first leg portion 15 of the other of the waveform units 14 axially adjacent to each other.
Patent AU-2021351541-A1 (AU)
Title: Methods for purification of messenger rna
Inventor: ABYSALH JONATHAN
IPC: C12N15/10
Filed: 2021-10-01
Abstract: The present invention relates, in part, to methods, systems and processes for large-scale purification of mRNA using a filtering centrifuge operating at lower gravitational forces. The invention also relates to compositions of purified mRNA and uses thereof.
Patent AU-2021363262-A1 (AU)
Title: Heterocyclic spiro compounds and methods of use
Inventor: LANMAN BRIAN ALAN
IPC: A61P35/00
Filed: 2021-10-19
Abstract: Provided are compounds of Formula (I) having activity as inhibitors of G12C mutant KRAS protein, pharmaceutical compositions comprising the compounds, and uses and methods of treating certain disorders, such as cancer, including but not limited to lung, pancreatic and colorectal cancers.
Patent AU-2021376672-A1 (AU)
Title: Receiving device for acoustic waves
Inventor: BRUNET JEAN-PHILIPPE
IPC: H04B11/00
Filed: 2021-08-30
Abstract: Disclosed is a receiving device for acoustic waves, comprising: - an acoustic antenna capable of having an electrostatic microphone function distributed along a line (L) of the acoustic antenna comprising a conductor (A) and a dielectric material (D), the line (L) being a transmission line or being configured to have a transmission line function when the dielectric material is in direct physical contact with another conductor, - an exciter (EX) configured to apply, during a reception step, an input voltage at a first longitudinal end (E1) of the line (L) so as to generate an input electromagnetic wave moving towards a second longitudinal end (E2) of the line (L) and so as to generate an output electromagnetic wave moving in the opposite direction from the input electromagnetic wave, the input voltage simultaneously comprising a set of sinusoidal voltages comprising a fundamental sinusoidal voltage and a set of harmonics of the fundamental sinusoidal voltage, the frequency of the fundamental sinusoidal voltage being defined so that stationary waves establish themselves in the line (L) so that the output electromagnetic wave comprises directional paths of the acoustic antenna.
Patent AU-2021380017-A1 (AU)
Title: Secure element arrays in internet-of-things systems
Inventor: MUKHA MATVEY
IPC: H04L9/40
Filed: 2021-11-12
Abstract: Systems and methods for providing secure execution of functions for edge devices include a plurality of edge devices, a controller, and an array of secure elements. The edge devices are each configured to obtain data for an application of the system. The controller is connected to communicate with the edge devices to receive the data from each of the edge devices. The array of secure elements is connected to the controller, and each secure element executes functions using the data received from the edge devices. The controller associates an identified secure element of the array of secure elements with a respective edge device to execute the functions for data received from the respective edge device, and the controller is connected to communicate a result of the executed functions to the respective edge device.